Takeda Submits Corporate Governance Report to Tokyo Stock Exchange

OSAKA, Japan, and CAMBRIDGE, Massachusetts, July 10, 2024 – Takeda (TSE:4502/NYSE:TAK) today filed its Corporate Governance Report with the Tokyo Stock Exchange (“TSE”) in accordance with the regulations* for TSE listed companies. The Report can be accessed on Takeda’s website at: https://www.takeda.com/about/corporate-governance/charters-and-reports/

The Report is prepared in line with the current Corporate Governance Code. It describes Takeda’s latest corporate governance features, including the new composition of the Board of Directors following the 148th General Shareholder’s Meeting held on June 26, 2024.

Key elements of Takeda’s Corporate Governance Report:

• Takeda ensures the transparency and objectivity of the Board of Directors’ discussions by maintaining a high ratio of independent external directors (three internal directors and 11 independent external directors) and having an independent external director serve as the chair of the board meeting.
• The Board of Directors is composed of diverse members with various background, experiences and knowledge (BOD Skill Matrix), to help enable strategic discussions and effective supervision of the Company.
• The Audit and Supervisory Committee and the Nomination/Compensation Committees, the latter being a voluntary advisory committees for the Board of Directors, are composed entirely of independent external directors, including each head/chairperson, in order to ensure the independence of each committee.
• The Board of Directors delegates a certain degree of authority to Takeda’s management. The Takeda Executive Team, which is diverse in background, nationality, gender and age, engages in agile and efficient decision-making based on strategic discussions at the management committee meetings.
• Takeda is in compliance with all of the principles requested of companies in the Prime Market under the current Corporate Governance Code.

Takeda’s latest Corporate Governance Report can be found on the information disclosure site operated by the Japan Exchange Group which consists of the TSE and other exchanges in Japan at: https://www2.jpx.co.jp/tseHpFront/CGK020010Action.do?Show=Show

Takeda also furnished the English version of the Corporate Governance Report with the U.S. Securities and Exchange Commission (the “SEC”), available at http://www.sec.gov.

Additionally, Takeda’s corporate governance strategy as well as overall sustainability and Environmental, Social and Governance information are explained in detail in its 2024 Annual Integrated Report for the fiscal year ended March 31, 2024, which was issued on July 1st. This report can be accessed on Takeda’s website at: https://www.takeda.com/investors/annual-integrated-report/

*TSE’s Securities Listing Regulations Rule 419.

About Takeda

Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit www.takeda.com.